Democratic Republic of the Congo (the)

in page functions
[French]
Congo Democratic Republic of the
Total population (2018) 84,825,197
Birth cohort (2018) 3,418,390
Surviving Infants (surviving to 1 year per year, 2018) 3,194,738
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 75/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 98/1000
World Bank Index, IDA (2015) 3.00
Gross Nation Income (per capita US$, 2015) 410
No. of districts/territories (2017) 516

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Congo Democratic Republic of the

Type of support

Approvals

2001-2023 (US$)
(23 May 2019)

Commitments

2001-2023 (US$)
(23 May 2019)

Disbursements

2000-2019 (US$)
(23 May 2019)

% Disbursed

(23 May 2019)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Total $909,344,396 $1,052,102,249 $834,538,572
Civil Society Organisation support (CSO) $9,757,132 $9,757,132 $9,857,132 101%
Cold Chain Equipment Optimisation Platform (CCEOP) $22,379,004 $22,379,004 $21,061,452 94%
Health system strengthening (HSS 1) $55,759,817 $55,759,817 $55,759,817 100%
Health system strengthening (HSS 2) $134,664,662 $148,852,874 $129,378,808 96%
Immunisation services support (ISS) $25,807,280 $25,807,280 $25,807,280 100%
Injection Safety Devices (NVS) $4,999,973 $8,696,973 $2,246,973 45%
Injection safety support (INS) $2,713,931 $2,713,931 $2,713,931 100%
IPV (NVS) $17,495,846 $17,495,846 $18,787,876 107%
Measles SIA (NVS) $11,710,012 $11,710,012 $11,710,012 100%
Measles SIA - Operational costs (OPC) $19,805,713 $19,805,713 $19,805,713 100%
Meningitis A - campaign (NVS) $13,744,023 $13,744,023 $13,744,023 100%
Meningitis A - operational costs (OPC) $11,645,500 $11,645,500 $11,645,500 100%
Penta (NVS) $175,045,005 $175,045,005 $177,461,285 101%
Pneumo (NVS) $279,581,988 $279,581,988 $274,696,971 98%
Product Switch Grant (PSG) $823,513 $823,513 $823,513 100%
Rotavirus (NVS) $8,742,000 $8,742,000 0%
Tetra DTP-HepB (NVS) $10,357,601 $10,357,601 $10,357,601 100%
Vaccine Introduction Grant (VIG) $8,051,003 $8,051,003 $6,592,615 82%
Yellow Fever (NVS) $40,928,736 $40,928,736 $42,088,070 103%
Yellow Fever - campaign (NVS) $34,794,500 $124,778,500
YF - Operational costs (OPC) $20,537,157 $55,425,797

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Congo Democratic Republic of the DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 94%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2012) 60.00%
Household survey: DTP3 coverage for female (2012) 61.10%
Household survey: Last DTP3 survey (2012) 61%
% districts achieving > 80% DTP3 coverage (2017) 91%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 80%

Breakdown of support

Non-vaccine support Vaccine support
34% 66%
$283,445,761 $551,092,811

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Congo Democratic Republic of the

11 June 2019

EPI LAMP Yaounde

New management training for immunisation leaders kicks-off at the University of Yaounde

National teams from six Gavi-supported countries will attend the first forum of the nine-month programme.

27 May 2019

DRC cholera vaccine

Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo

Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges.

20 May 2019

WHA Palais

72nd World Health Assembly

With senior health officials setting the annual direction for the World Health Organization this week, multiple health challenges and considerations vie for attention amidst a packed agenda. Find out how Gavi helps ensure that immunisation is recognised for its vital role in bringing essential health care to all.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here